Le Lézard
Classified in: Covid-19 virus
Subjects: NPT, POL, FVT

Senator Cory Booker & Former U.S. Attorney General Eric Holder to Speak at The Fortune Society's "Hope & Justice Gala"


NEW YORK, Nov. 9, 2020 /PRNewswire/ -- U.S. Senator Cory Booker (D - NJ) and Eric H. Holder, Jr., the 82nd Attorney General of the United States and Chairman of the National Democratic Redistricting Committee will be featured guest speakers at Hope & Justice, The Fortune Society's annual gala taking place virtually on Monday, November 16, 2020 at 7:00 p.m. Senator Booker and Mr. Holder, both stalwart champions of justice reform, will address a virtual crowd of business and civic leaders, philanthropists, criminal justice advocates, and other Fortune supporters. The event is expected to raise almost $1 million.

The Fortune Society, a leading nonprofit reentry service and advocacy organizations serving thousands of justice-involved individuals every year, will present its Game Changer Award to VICE Media Group in recognition of its in-depth and insightful criminal justice coverage across its various platforms including its award-winning editorial work for VICE.com; dynamic digital video and audio units; and VICE News Tonight, the most Emmy-winning nightly newscast on television three years in a row.  Keegan Hamilton, senior reporter, podcast host, and Emmy-nominated producer at VICE News, will accept the award on behalf of VICE Media Group.

Honored with the Frontline Hero Awards will be three Fortune staff members: Barry Campbell, Interim Director of Fortune's Freedom House; Judy De La Cruz, Manager of Training; and Samantha Pugh, Senior Director of the ICAN & Adult Mentoring Program. They will be recognized for their tireless efforts providing crucial, uninterrupted services to people with justice involvement during the COVID-19 pandemic.

The event will also offer show-stopping performances by Tony Award-winning singer and actress Christine Ebersole and international jazz vocalist, recording artist and entertainer Thos Shipley.

JoAnne Page, Fortune's President and CEO said, "Our honorees and special guests have an enduring commitment to justice and humanity. Each works to tear down barriers that thwart equal justice, while working to rebuild lives through a fairer justice system."

Funds raised will support Fortune's comprehensive array of wraparound services including substance use and mental health treatment, alternatives to incarceration, HIV/AIDS case management, health services, career development and job retention, education, family services, housing and lifetime access to aftercare.

Media Contact:
Colleen Roche
914-370-0654
[email protected]

SOURCE The Fortune Society


These press releases may also interest you

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Jon Hamm Praises the Resilience of Saint Louis University's Class of 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Bentley University Class of 2024 Celebrates Resilience, Achievement as Graduation Marks Culmination of a Historic Four Years
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

More news about Covid-19 virus...


News published on and distributed by: